TET2 and glioblastoma: Ectopic expression of TET2 impairs tumor growth capacity of GBM cells and this phenotype is associated with activation of neural differentiation programs.34,49 These findings suggest that TET2 and 5hmC regulate the tumor phenotype of GBM by controlling the stem cell phenotype of GBM cells.